Urology & Urogynecology 11 mins Videourodynamic Evaluation: An Introduction for Clinicians Get an introduction to videourodynamic evaluation, including key techniques, clinical... Written By Laborie
Urology & Urogynecology 4 mins Laborie’s Optilume® Drug-Coated Balloon for Stricture Secures Coverage from BCBS of Michigan Effective July 1, 2025, Blue Cross Blue Shield of Michigan... Written By Laborie
Urology & Urogynecology 4 mins Three-Year Data from ROBUST III Confirms Long-Term Durability of Optilume® Drug-Coated Balloon for Recurrent Urethral Strictures Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic... Written By Laborie
Urology & Urogynecology 3 mins Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and... Written By Laborie
Uncategorized @au | Urology & Urogynecology 3 mins Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association Laborie Medical Technologies Corp (Laborie), announced today that the American... Written By Laborie
Urology & Urogynecology 3 mins Laborie Unveils Positive Study Results for Optilume® BPH Catheter System Laborie announced positive 2-year and 5-year results from studies for... Written By Laborie
Urology & Urogynecology 5 mins NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme Laborie welcomed the inclusion of Optilume® Urethral Drug-Coated Balloon (DCB)... Written By Laborie
Urology & Urogynecology 3 mins Laborie Medical Technologies Invests in iO Urology and the CarePath Uroflow Device Laborie Medical Technologies announced a strategic equity investment in Bright... Written By Laborie
Uncategorized @au | Urology & Urogynecology 5 mins Laborie Medical Technologies Acquires Urotronic Urotronic joins Laborie as part of a long-term growth strategy... Written By Laborie
